Show simple item record

dc.contributor.authorLumala, R
dc.contributor.authorvan den Akker, T
dc.contributor.authorMetcalf, CA
dc.contributor.authorDiggle, E
dc.contributor.authorZamadenga, B
dc.contributor.authorMbewa, K
dc.contributor.authorAkkeson, A
dc.date.accessioned2017-03-31T18:59:21Z
dc.date.available2017-03-31T18:59:21Z
dc.date.issued2012-06-01
dc.date.submitted2017-03-30
dc.identifier.citationCD4 Testing at Clinics to Assess Eligibility for Antiretroviral Therapy. 2012, 24 (2):25-8 Malawi Med Jen
dc.identifier.issn1995-7270
dc.identifier.pmid23638266
dc.identifier.urihttp://hdl.handle.net/10144/618887
dc.description.abstractIn 2011, the Ministry of Health raised the CD4 threshold for antiretroviral therapy (ART) eligibility from <250 cells/µl and <350 cells/µl, but at the same time only 8.8% of facilities in Malawi with HIV services provided CD4 testing. We conducted a record review at 10 rural clinics in Thyolo District to assess the impact of introducing CD4 testing on identifying patients eligible for ART.
dc.language.isoenen
dc.publisherCollege of Medicine, University of Malawien
dc.rightsArchived with thanks to Malawi Medical Journal : the journal of Medical Association of Malawien
dc.subjectviral loaden
dc.subject.meshAdolescenten
dc.subject.meshAdulten
dc.subject.meshAgeden
dc.subject.meshAmbulatory Careen
dc.subject.meshAnti-Retroviral Agentsen
dc.subject.meshCD4 Lymphocyte Counten
dc.subject.meshEligibility Determinationen
dc.subject.meshFemaleen
dc.subject.meshHIV Infectionsen
dc.subject.meshHealth Care Rationingen
dc.subject.meshHealth Services Needs and Demanden
dc.subject.meshHumansen
dc.subject.meshMalawien
dc.subject.meshMaleen
dc.subject.meshMiddle Ageden
dc.subject.meshPrevalenceen
dc.subject.meshRetrospective Studiesen
dc.subject.meshRural Populationen
dc.subject.meshSocioeconomic Factorsen
dc.subject.meshYoung Adulten
dc.titleCD4 Testing at Clinics to Assess Eligibility for Antiretroviral Therapyen
dc.identifier.journalMalawi Medical Journal : the journal of Medical Association of Malawien
refterms.dateFOA2019-03-04T13:19:55Z
html.description.abstractIn 2011, the Ministry of Health raised the CD4 threshold for antiretroviral therapy (ART) eligibility from <250 cells/µl and <350 cells/µl, but at the same time only 8.8% of facilities in Malawi with HIV services provided CD4 testing. We conducted a record review at 10 rural clinics in Thyolo District to assess the impact of introducing CD4 testing on identifying patients eligible for ART.


Files in this item

Thumbnail
Name:
Lumala R et al - 2012 - CD4 ...
Size:
594.0Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record